Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 68,520 | 21,661 | 95,401 | 58,056 | 35,045 |
| Marketable Securities | N/A | 36,978 | 0 | 5,080 | 24,385 |
| Receivables | 25,423 | 18,981 | 16,651 | 15,049 | 14,610 |
| Inventories | 19,689 | 13,884 | 13,003 | 15,088 | 20,114 |
| TOTAL | $117,663 | $96,096 | $127,106 | $94,801 | $96,671 |
| Non-Current Assets | |||||
| PPE Net | 17,531 | 8,056 | 8,825 | 12,301 | 16,525 |
| Intangibles | 146,769 | 150,308 | 161,508 | 172,708 | 183,908 |
| Other Non-Current Assets | 42,794 | 10,352 | 6,208 | 7,541 | 9,291 |
| TOTAL | $207,094 | $168,716 | $176,541 | $192,550 | $209,724 |
| Total Assets | $324,757 | $264,812 | $303,647 | $287,351 | $306,395 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,220 | 5,152 | 4,027 | 4,211 | 3,967 |
| Accrued Expenses | 13,787 | 5,160 | 14,470 | 10,535 | 3,996 |
| TOTAL | $54,249 | $32,821 | $37,582 | $33,474 | $29,500 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 16,387 | 11,803 | 11,464 | 10,238 | 9,163 |
| Other Non-Current Liabilities | 93,735 | 58,717 | 173,908 | 201,063 | 198,207 |
| TOTAL | $131,458 | $78,379 | $193,949 | $222,942 | $223,662 |
| Total Liabilities | $185,707 | $111,200 | $231,531 | $256,416 | $253,162 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,547 | 70,446 | 68,989 | 38,812 | 29,208 |
| Common Shares | 75 | 70 | 49 | 39 | 29 |
| Retained earnings | -676,761 | -623,641 | -558,851 | -500,196 | -439,477 |
| Other shareholders' equity | 112 | -582 | -687 | -574 | -760 |
| TOTAL | $139,050 | $153,612 | $72,116 | $30,935 | $53,233 |
| Total Liabilities And Equity | $324,757 | $264,812 | $303,647 | $287,351 | $306,395 |